Phio Pharmaceuticals (PHIO) News Today → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free PHIO Stock Alerts $0.78 0.00 (0.00%) (As of 05/20/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 19 at 4:14 PM | investing.comPhio Pharmaceuticals secures investment from TRITON FundsMay 17, 2024 | finanznachrichten.dePhio Pharmaceuticals Corp.: Phio Pharmaceuticals Secures New InvestorMay 17, 2024 | globenewswire.comPhio Pharmaceuticals Secures New InvestorMay 17, 2024 | americanbankingnews.comFY2024 EPS Estimates for Phio Pharmaceuticals Corp. (NASDAQ:PHIO) Boosted by HC WainwrightMay 16, 2024 | finance.yahoo.comPhio Pharmaceuticals Presents This Week at the Society for Investigative Dermatology (SID)May 16, 2024 | americanbankingnews.comPhio Pharmaceuticals (NASDAQ:PHIO) Rating Reiterated by HC WainwrightMay 16, 2024 | americanbankingnews.comEquities Analysts Issue Forecasts for Phio Pharmaceuticals Corp.'s Q2 2024 Earnings (NASDAQ:PHIO)May 15, 2024 | globenewswire.comPhio Pharmaceuticals Announces Completion of Dosing in First Patient Cohort in PH-762 Phase 1b Dose-Escalation StudyMay 15, 2024 | markets.businessinsider.comBuy Rating Affirmed for Phio Pharmaceuticals Amid Promising INTASYL Technology and PH-762 Clinical ProgressMay 10, 2024 | finanznachrichten.dePhio Pharmaceuticals Corp.: Phio Pharmaceuticals Reports Q1 2024 Results and Provides Business UpdateMay 9, 2024 | globenewswire.comPhio Pharmaceuticals Reports Q1 2024 Results and Provides Business UpdateApril 30, 2024 | globenewswire.comPhio Pharmaceuticals Announces Upcoming Presentation at the Annual Meeting of the Society of Clinical Oncology (ASCO)April 24, 2024 | investing.comPhio Pharmaceuticals reports progress on cancer therapy PH-762April 22, 2024 | benzinga.comWhy Is Penny Stock Phio Pharmaceuticals Trading Higher On Monday?April 22, 2024 | finance.yahoo.comIntratumoral Injection of Phio’s PH-762 significantly inhibits tumor growth in murine tumor models and may generate memory-specific T cellsApril 22, 2024 | globenewswire.comIntratumoral Injection of Phio's PH-762 significantly inhibits tumor growth in murine tumor models and may generate memory-specific T cellsApril 16, 2024 | globenewswire.comPhio Pharmaceuticals Announces Upcoming Presentations at the 81st Annual Meeting of the Society for Investigative Dermatology (SID)April 11, 2024 | globenewswire.comPhio Pharmaceuticals Announces Upcoming Presentation at the 27th Annual Meeting of the American Society of Cell and Gene Therapy (ASCGT)April 3, 2024 | finance.yahoo.comNational Spotlight Features Phio’s Innovative RNAi Technology PlatformApril 3, 2024 | globenewswire.comNational Spotlight Features Phio's Innovative RNAi Technology PlatformApril 2, 2024 | globenewswire.comPhio Pharmaceuticals Reports 2023 Year End Financial Results and Provides Business UpdateMarch 21, 2024 | finance.yahoo.comPhio Pharmaceuticals Presenting Data Showing INTASYL May Result in More Effective Cell Therapy for Hematological MalignanciesMarch 13, 2024 | globenewswire.comPhio Pharmaceuticals Announces Addition of Clinical Trial Sites at Banner MD Anderson Cancer Center, The George Washington University, and Integrity ResearchMarch 10, 2024 | morningstar.comPhio Pharmaceuticals Corp PHIOMarch 6, 2024 | markets.businessinsider.comAnalysts Are Bullish on These Healthcare Stocks: Neurogene (NGNE), Akero Therapeutics (AKRO)March 6, 2024 | finance.yahoo.comPhio Pharmaceuticals Announces Patent Granted by USPTO, Strengthening the Company’s Intellectual Property Position in Treating Aging Skin and Skin DisordersMarch 6, 2024 | globenewswire.comPhio Pharmaceuticals Announces Patent Granted by USPTO, Strengthening the Company's Intellectual Property Position in Treating Aging Skin and Skin DisordersFebruary 14, 2024 | uk.finance.yahoo.comDry Age Related Macular Degeneration Market Report 2024: Global Trends, Forecasts and Competitive Analysis 2018-2023 and 2024-2030February 6, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN) and Phio Pharmaceuticals (PHIO)January 31, 2024 | finance.yahoo.comPhio Pharmaceuticals Announces Data Showing INTASYL May Result in More Effective Cell Therapy for Hematological MalignanciesDecember 19, 2023 | msn.comPhio Pharmaceuticals files to sell 4.42M shares of common stock for holdersDecember 7, 2023 | msn.comWhy Phio Pharmaceuticals Stock Is NosedivingDecember 7, 2023 | finance.yahoo.comPhio Pharmaceuticals Announces Exercise of Warrants for $2.8 Million Gross ProceedsNovember 10, 2023 | finanznachrichten.dePhio Pharmaceuticals Corp.: Phio Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business UpdateNovember 10, 2023 | msn.comPhio Pharmaceuticals GAAP EPS of -$1.14 beats by $0.29November 9, 2023 | finance.yahoo.comPhio Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business UpdateNovember 9, 2023 | finance.yahoo.comPhio Pharmaceuticals Announces First US Patient Enrolled in Phase 1B Clinical Trial with Intratumoral PH-762 anti-PD-1 Therapy for Treatment of Skin CarcinomasNovember 3, 2023 | finanznachrichten.dePhio Pharmaceuticals Corp.: Phio Pharmaceuticals Presents New Data Showing INTASYL Compound targeting CTLA-4 Enhances Tumor ControlNovember 3, 2023 | finance.yahoo.comPhio Pharmaceuticals Presents New Data Showing INTASYL Compound targeting CTLA-4 Enhances Tumor ControlOctober 12, 2023 | finance.yahoo.comPhio Pharmaceuticals Announces Upcoming Presentation at the 38th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)October 12, 2023 | finance.yahoo.comPHIO Jumps 91% on Encouraging Preclinical Cancer Drug DataOctober 11, 2023 | marketwatch.comPhio Pharmaceuticals Shares Up 60% on Favorable PH-894 Preclinical DataOctober 11, 2023 | markets.businessinsider.comCrude Oil Down 2.5%; Silk Road Medical Shares PlummetOctober 11, 2023 | msn.comPhio Pharmaceuticals, Exscientia among healthcare moversOctober 11, 2023 | benzinga.comWhy Is Immuno-Oncology Focused Phio Pharmaceuticals Stock Trading Higher Today?October 11, 2023 | finance.yahoo.comPhio Pharmaceuticals Presents New Data for Targeting of BRD4 with its INTASYL™ Compound PH-894September 6, 2023 | finance.yahoo.comPhio CEO to Speak at Wainwright Conference in New York in SeptemberSeptember 6, 2023 | finance.yahoo.comPhio CEO to Speak at Wainwright Conference in New York in SeptemberAugust 22, 2023 | msn.comPhio’s partners dose first patient in cancer combo therapy trialAugust 21, 2023 | finance.yahoo.comPhio Pharmaceuticals Announces Dosing of First Patient in Collaborative Clinical Trial with AgonOx, Inc. and Providence Cancer Institute Get Phio Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for PHIO and its competitors with MarketBeat's FREE daily newsletter. Email Address Does this make you sick? (Ad)The US Dollar Is "Finished" A deteriorating economy, global instability, and a weakened banking system have pushed the U.S. financial system to the brink, imperiling the value of your savings and investments. Get your Free Wealth Protection Kit PHIO Media Mentions By Week PHIO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PHIO News Sentiment▼0.540.43▲Average Medical News Sentiment PHIO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PHIO Articles This Week▼161▲PHIO Articles Average Week Get Phio Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for PHIO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: LGVN News Today NBY News Today REVB News Today ARDS News Today BCEL News Today ARAV News Today CWBR News Today BPTS News Today GOVX News Today MBIO News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PHIO) was last updated on 5/21/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsDoes this make you sick?Allegiance Gold[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 Media**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsBill Gates is all about this tiny $2 stockTimothy Sykes4 Cryptos BETTER than BitcoinTrue Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Phio Pharmaceuticals Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
